Dengue virus (DENV) infection causes dengue fever, dengue haemorrhagic fever, or dengue shock syndrome. Mast cells have been speculated to play a role in DENV disease although their precise roles are unclear. In this study, we used mast cell-deficient Kit W-sh/W-sh mice to investigate the involvement of mast cells after intradermal DENV infection. An approximately two-to three-fold higher level of DENV NS3 antigen was detected at the skin inoculation site in DENV-infected Kit W-sh/W-sh mice than in DENV-infected wild-type (WT) mice (using a dose of 1 3 10 9 plaqueforming units/mouse). Moreover, as an indicator of heightened pathogenesis, a more prolonged bleeding time was observed in DENV-infected Kit W-sh/W-sh mice than in WT mice. Monocytes/macrophages are considered to be important targets for DENV infection, so we investigated the susceptibility and chemokine response of DENV-infected peritoneal macrophages from Kit W-sh/W-sh and WT mice both ex vivo and in vivo. There was a tendency for higher DENV infection and higher secretion of CCL2 (MCP-1) from peritoneal macrophages isolated from Kit W-sh/W-sh mice than those from WT mice. In vivo studies using intradermal inoculation of DENV showed about twofold higher levels of infiltrating macrophages and CCL2 (MCP-1) at the inoculation site in both mock control and DENV-inoculated Kit W-sh/W-sh mice than in corresponding WT mice. In summary, compared with WT mice, Kit W-sh/W-sh mice show enhanced DENV infection and macrophage infiltration at the skin inoculation site as well as increased DENV-associated bleeding time. The results indicate an intriguing interplay between mast cells and tissue macrophages to restrict DENV replication in the skin.
Introduction
Dengue virus (DENV) is a positive-sense single-stranded RNA virus. DENV belongs to the genus Flavivirus of the family Flaviviridae and consists of four serotypes DENV1, 2, 3 and 4. Patients infected by DENV may display a range of clinical syndromes from asymptomatic infection to a self-limiting febrile illness, dengue fever, to severe dengue disease, dengue haemorrhagic fever and dengue shock syndrome. The pathogenic mechanisms are not fully resolved. 1, 2 Dengue has now become a major international public health concern. There are about 390 million dengue infections each year, of which 96 million cases occur with clinical manifestations. 3, 4 Better understanding of dengue pathogenic mechanisms is of high importance for rational development of a protective vaccine or specific antiviral drug.
Mast cells arise from bone marrow-derived precursors that circulate in blood and become differentiated after entering tissues. 5, 6 Mast cells are resident in tissues throughout the body but are most common at sites that are exposed to the external environment, such as skin, Abbreviations: BSA, bovine serum albumin; DENV, dengue virus; FBS, fetal bovine serum; i.d., intradermally; MOI, multiplicity of infection; NK, natural killer cells; p.i., post-infection; WT, wild-type
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airway and intestine. 5 Mast cells are known to play critical roles in maintaining a healthy physiology, in wound healing and the defence of pathogens, participating in innate and adaptive immunity. Mast cells are also involved in the inflammatory process, recruiting different leucocytes to the site of injury and in allergic disease. 7 Several studies showed that mast cells are involved in the mechanisms of antiviral defence and in viral disease pathogenesis. For example, mast cells could cause lung injury resulting from H5N1 influenza virus infection by releasing pro-inflammatory mediators. 8 Mast cells are also involved in host defence at herpes simplex virus-infected sites through tumour necrosis factor-a (TNF-a) and interleukin-6 (IL-6) production, which are induced by keratinocyte-derived IL-33. 9 In the case of dengue, urinary and blood histamine levels are elevated in patients with dengue haemorrhagic fever. 10 A recent report showed the elevation of mast cellderived vascular endothelial growth factor and proteases in patients with dengue shock syndrome. 11 Mast cellderived chymase also promotes vascular leakage in DENV-infected mice. 12 In vitro studies indicated that antibody-enhanced DENV infection of mast cells selectively induces production of chemokines CCL3 (MIP-1a), CCL4 (MIP-1b) and CCL5 (RANTES), 13 as well as cytokines IL-6, IL-1b and TNF-a. 14 The TNF-a produced from antibody-enhanced DENV infection of mast cells can trigger endothelial cell activation. 15 Mast cells infected with several viruses including DENV produce a spectrum of chemokines that recruit specific leucocytes including natural killer (NK) cells. [16] [17] [18] In a mouse model of DENV infection, mast cells were implicated in recruitment of NK and NKT cells, which may clear virus. 18 RNA sensors, particularly RIG-I, enable human mast cell antiviral chemokine production and interferon-mediated protection in response to antibody-enhanced DENV infection. 16 Localized responses of mast cells to DENV are protective through immune cell recruitment and viral clearance, whereas mast cell-induced vascular leakage systemically can contribute to DENV pathogenesis. 19 Mast cell-deficient Kit W-sh/W-sh mice are often used as a model to study the function of mast cells in human disease. 20, 21 Previous studies indicated that mast cells, at least in the human, develop from CD34 + CD117 + (c-Kit) progenitor cells originating in the bone marrow and mature within tissues. 22 Mast cells at all stages of maturation express the receptor tyrosine kinase Kit. The ligand of Kit is stem cell factor, which can induce Kit dimerization and auto-phosphorylation in the progression of mast cell maturation. Hence, Kit W-sh/W-sh mice, in which surface expression of Kit or Kit catalytic activity is defective, have significantly reduced mast cell numbers. 23 In the present study, we used mast cell-deficient Kit W-sh/W-sh mice to determine the involvement of mast cells in DENV infection and disease.
Materials and methods

Mice
Wild-type (WT) C57BL/6 mice were obtained from Charles River Breeding Laboratories (Wilmington, MA) and maintained on standard laboratory food and water in the Laboratory Animal Centre of the National Cheng Kung University Medical College. STOCK Kit W-sh /HNihrJaeBsmJ (Kit W-sh/W-sh ) mice were obtained from the Jackson Laboratory (Bar harbor, ME) and maintained at the National Laboratory Animal Centre, Tainan facility. The animal-use protocol was reviewed and approved by the Institutional Animal Care and Use Committee. Six-week-old progeny of WT C57BL/6 and Kit W-sh/W-sh mice were used for the DENV infection experiments. In this study, the 6-week-old Kit W-sh/W-sh mice had approximately 12% of the number of skin mast cells compared with WT mice. This percentage is very similar to that reported in a previous study. 24 Virus culture DENV2 16681 was propagated in C6/36 cells. Briefly, monolayers of C6/36 cells were inoculated with DENV at a multiplicity of infection (MOI) of 0Á01 and incubated at 28°in 5% CO 2 for 5 days. The culture medium was harvested and cell debris was removed by centrifugation at 2000 g for 5 min. The virus supernatant was collected and stored at À70°until use in experiments. In some experiments, high-titre DENV was prepared by concentrating virus supernatant using Centrifugal Filters (30-kDa cut off) (Amicon; Millipore, Billerica, MA) by centrifugation. Virus titre was determined by plaque assay using the BHK-21 cell line as described below.
Plaque assay
BHK-21 cells were plated into 12-well plates (2 9 10 5 cells/well) and cultured overnight in Dulbecco's modified Eagle's medium (DMEM) at 37°in a humidified atmosphere of 5% CO 2 . After adsorption with a serially diluted virus inoculum for 1 hr, the inoculum was replaced with fresh DMEM containing 2% fetal bovine serum (FBS) and 0Á5% methyl cellulose. At 5 days postinfection (p.i.), the medium was removed, and the cells were fixed and stained with crystal violet solution (1% crystal violet, 0Á64% NaCl and 2% formalin).
Animal model
Mice were intradermally (i.d.) inoculated with 200 µl DENV [10 9 plaque-forming units (PFU)/mouse] at four sites (50 µl/site) on the upper back as previously described. 25 Mice were killed 2 or 3 days p.i.
Bleeding time
Bleeding time was measured by a 3-mm tail-tip transection. Blood droplets were collected on filter paper every 30 seconds. Bleeding time was recorded when the blood spot was smaller than 0Á1 mm in diameter. 26, 27 Immunohistochemistry staining
Skin sections were embedded in paraffin and sliced on slides. Slides were deparaffinized using xylene and an alcohol gradient (100%, 95%, 85%, 70% and 50%). The sections were incubated in 2 M HCl solution for 20 min and then treated with 20 µg/ml proteinase K in TE buffer (50 mM Tris Base, 1 mM EDTA, and 0Á5% Triton X-100, pH 8Á0) for another 20 min at room temperature. The sections were incubated with 3Á5% H 2 O 2 in PBS for 15 min to inhibit endogenous peroxidase activity and blocked by 5% BSA in PBST for 30 min. The primary and secondary antibodies were appropriately diluted in antibody diluents (Dako Corporation, Glostrup, Denmark). Primary antibodies including rabbit anti-DENV2 NS3 (1 : 500, GeneTex, Irvine, CA), rat anti-mouse F4/80 (1:50, Serotec, Raleigh, NC), and rabbit anti-mouse CCL2 (MCP-1) (1 : 300, Abcam, Cambridge, UK) were incubated overnight at 4°, followed by biotin-labelled donkey anti-rabbit antibody (Jackson Immunoresearch Laboratories, West Grove, PA) or donkey anti-rat antibody (Jackson Immunoresearch Laboratories), respectively, for 2 hr at room temperature. After washing twice with PBST, the sections were incubated with horseradish peroxidase-conjugated streptavidin (Dako Corporation) for 15 min at room temperature. The skin sections were developed with the AEC substrate kit (Vector Laboratories, Burlingame, CA) and nuclei were stained with haematoxylin for 3 min. The sections were analysed using a TissueFAXS (TissueGnostics Vienna, Austria) image cytometer. Cells were counted in 15 regions per mouse field and the average numbers were calculated by HISTOQUEST software (TissueGnostics). HISTOQUEST separated the antibody-mediated chromogen (AEC) stain and the counterstain (haematoxylin). The positive cells were detected by signals of AEC in the nucleated cells. Results were displayed as dot plots with each dot representing a single cell in the tissue sample. The cut-off threshold was determined by the AEC signal intensity based on AECnegative cells in the same section. The forward/backward gating tool of HISTOQUEST software was used for quality control of measurements. By clicking on high or low AEC staining intensity cells in the image, the forward gating tool showed the individual staining intensities of selected cells in the scattergram. Backward gating was used to verify data by visual inspection on the original image. 28 
Isolation of murine peritoneal macrophages
Mice were killed by cervical dislocation, and cleaned with 70% ethanol. Mice were injected intraperitoneally with 5 ml 4°PBS and the peritoneum was gently massaged to collect any attached cells. Recovered cells were centrifuged at 1000 g for 10 min at 4°. Cells were resuspended in 5 ml of RPMI-1640 medium (CAISSON) containing 10% FBS and antibiotics and plated in 6-cm Petri dishes. After 30 min of incubation at 37°with 5% CO 2 , non-adherent cells were removed by PBS washing. The peritoneal macrophages were cultured with RPMI-1640 medium before DENV infection studies, as described below.
Ex vivo DENV infection
Mouse peritoneal macrophages were aliquoted into 24-well plates (2 9 10 5 cells/well). Cells were incubated for 1Á5 hr at 4°in RPMI-1640 with 2% FBS (mock) or DENV at MOI of 10 or 50. At 1Á5 hr p.i., the virus was removed. Cells and cell supernatants were collected at 48 and 72 hr p.i.
Detection of infection
Peritoneal macrophages were washed briefly in PBS and fixed with 1% formaldehyde at room temperature for 10 min, and then washed again with PBS. Cells were incubated with normal human serum (1 : 10) at 4°for 1 hr. After washing with PBS and permeabilization buffer (1% BSA, 0Á1% saponin and 15 mM NaN 3 ), cells were incubated with rabbit anti-DENV2 NS4B antibody (1 : 500, GeneTex) at 4°for 1 hr. After washing twice with permeabilization buffer, the cells were incubated with Alexa-488-conjugated donkey anti-rabbit IgG (Invitrogen, Carlsbad, CA) at 4°for 30 min. DENV infection (DENV2 NS4B-positive cells) was analysed by flow cytometry (FACSCalibur; BD Biosciences, San Jose, CA) with excitation set at 488 nm. The percentage of positive cells was determined by comparison with the mock-infected group.
ELISA of CCL2 (MCP-1) levels
CCL2 (MCP-1) levels were measured by a sandwich ELISA technique with commercial ELISA development kits (R&D Systems, Minneapolis, MN). The 96-well plates were coated with diluted capture antibodies in PBS and incubated overnight at room temperature. After washing three times with wash buffer (0Á05% Tween-20 in PBS) and blocking with blocking buffer (1% BSA in PBS) for 1 hr, cell culture supernatants and standards were diluted with reagent diluents (1% BSA in PBS) and then added into plates for 2 hr incubation at room temperature. After washing, the detection antibodies in reagent diluents (1% BSA in PBS) were added and incubated for 2 hr. After washing, streptavidin-horseradish peroxidase (1 : 200) was added for 20 min. Finally, the substrate solution tetramethylbenzidine (TMB) (Clinical Science Products, Mansfield, MA) was added and the reaction was stopped with 1 M H 2 SO 4 . The optical density was determined using a microplate reader set to 450 nm.
Statistics
Comparisons between various treatments were performed by unpaired t-test with GRAPHPAD PRISM version 5.0 (GraphPad, San Diego, CA). Statistical significance was set at P < 0Á05.
Results
DENV antigen and viral RNA expression at the skin inoculation site in WT and Kit W-sh/W-sh mice
We sought to determine possible differences between Kit W-sh/W-sh and WT mice with respect to DENV infection at the skin inoculation site. Mice were infected with 1 9 10 9 PFU/mouse of DENV and killed on day 2 or 3 ( Fig. 1a) . We detected the expression of DENV antigen NS3, a marker for viral replication, at the skin inoculation site by immunohistochemical staining. Immunohistochemical staining showed that few cells in the dermis layer expressed NS3 on day 2 (Fig. 1b) . Immunohistochemical stained images were further quantified by HISTOQUEST software. The results of HISTO-QUEST analysis showed that the percentage of NS3-positive cells was significantly higher in DENV-infected Kit W-sh/W-sh mice compared with that in DENV-infected WT mice (1Á03 AE 0Á23% versus 0Á38 AE 0Á11%, about a 2Á7-fold change; P < 0Á05) (Fig. 1c) . By day 3, we found that there were more NS3-positive cells in the dermis layer (Fig. 1d) . We further quantified these immunohistochemical stained images by HISTOQUEST software. The results of HISTOQUEST analysis also showed that the percentage of NS3-positive cells was higher, although not statistically significantly, in DENVinfected Kit W-sh/W-sh mice compared with that in DENV-infected WT mice (1Á17 AE 0Á26% versus 0Á58 AE 0Á14%, about a twofold change; P = 0Á0665) (Fig. 1e) . Using rabbit IgG as negative control antibody for the NS3 staining, the results showed that there was no significant difference between those four groups (see Supplementary material, Fig. S1 ). The results therefore indicate that DENV infection does not lead to an increase in autofluorescence or non-specific staining. We further performed in situ hybridization to confirm a higher viral RNA level in DENV-infected Kit W-sh/W-sh mice compared with that in DENV-infected WT mice (see Supplementary material, Fig. S2 ).
Bleeding times of DENV-infected WT and Kit
W-sh/W-sh mice Our previous study showed that DENV infection caused prolonged bleeding time in WT mice. 29 As increased bleeding time is an important indicator of DENV pathogenesis, we inoculated WT and Kit W-sh/W-sh mice with 1 9 10 9 PFU/mouse of DENV and determined the bleeding time on 2 and 3 days p.i. The results showed that DENV infection caused prolonged bleeding time, both in WT and Kit W-sh/W-sh mice. However, the bleeding time was longer in DENV-infected Kit W-sh/W-sh mice than in WT mice (Fig. 2) .
Infection of DENV and production of CCL2 (MCP-1) in ex vivo peritoneal macrophages isolated from WT and Kit W-sh/W-sh mice CCL2 (MCP-1) is a highly expressed chemokine in patients with dengue haemorrhagic fever/dengue shock syndrome that may act on endothelial cells, causing permeability changes and contributing to plasma leakage. [30] [31] [32] [33] In addition, CCL2 (MCP-1) contributes to the migration and infiltration of monocytes/macrophages, memory T cells and NK cells, which are involved in dengue disease pathogenesis. Isolated peritoneal macrophages from WT and Kit W-sh/W-sh mice were infected with DENV at an MOI of 10 or 50. At 48 or 72 hr p.i., we used flow cytometry to analyse the expression of NS4B, a DENV replication marker. Results showed that at both 48 and 72 hr p.i., DENV infection of peritoneal macrophages was higher, although not statistically significantly, in those from Kit W-sh/W-sh than in WT mice (Fig. 3a) . A set of representative dot plots and histograms of each group is shown in the Supplementary material (Fig. S3) . We further detected the production of CCL2 (MCP-1) in the culture supernatants from DENVinfected peritoneal macrophages from WT and Kit W-sh/W-sh mice. The results showed that the levels of CCL2 (MCP-1) were higher, although not statistically significantly, in supernatants from peritoneal macrophages isolated from Kit W-sh/W-sh mice compared with those isolated from WT mice (Fig. 3b) . A tendency for higher infection of peritoneal macrophages isolated from Kit W-sh/W-sh mice than those from WT mice was also observed using a lower MOI (see Supplementary material, Fig. S4 ). . 25 We further determined the numbers of infiltrating macrophages (F4/80-positive cells) and expression of CCL2 (MCP-1) at the skin inoculation site in WT and Kit W-sh/W-sh mice infected in vivo with DENV (1 9 10 9 PFU/mouse) or medium as mock control. At 3 days p.i., we detected F4/ 80-positive macrophage infiltration in the dermis layer at the skin inoculation site by immunohistochemical staining (Fig. 4a) . Immunohistochemical staining images were further quantified using HISTOQUEST analysis software (Fig. 4b) . Interestingly, we found that the basal numbers of infiltrating macrophages were higher in mock-infected Kit W-sh/W-sh mice than in WT mice (5Á50 AE 0Á47% versus 2Á97 AE 0Á37%, about a twofold change; P < 0Á001). After DENV infection, the numbers of infiltrating macrophages were significantly increased in Kit W-sh/W-sh mice and were higher than in WT mice (9Á69 AE 1Á36% versus 6Á64 AE 0Á59%, about a 1Á5-fold change; P < 0Á05). For CCL2 (MCP-1) production, we also found that CCL2 (MCP-1)-positive cells in the dermis layer (Fig. 5a ) and the basal levels of CCL2 (MCP-1) were higher in Kit W-sh/W-sh mice than in WT mice (4Á54 AE 0Á54% versus 1Á90 AE 0Á24%, about a 2Á4-fold change; P < 0Á001) (Fig. 5b) . After DENV infection, the levels of CCL2 (MCP-1) were significantly increased in Kit W-sh/W-sh mice and were higher than in WT mice (10Á87 AE 1Á34% versus 5Á59 AE 0Á86%, about a twofold change; P < 0Á01) (Fig. 5b) . There was no significant difference when comparing the mock group with the non-injected group with regard to macrophage infiltration or MCP-1 production (see Supplementary material, Fig. S5 ), which excludes the possibility that macrophage infiltration and MCP-1 production might be induced by the intradermal injection itself.
Macrophage infiltration and production of CCL2 (MCP-1) in WT and
Discussion
The present study offers new insights into the roles of mast cells in dengue infection. Most importantly, we show higher levels of DENV replication at the site of intradermal inoculation, as well as increased bleeding time, an important indicator of pathogenesis, in mast cell-deficient Kit W-sh/W-sh mice compared with WT mice. Furthermore, the observed heightened macrophage infiltration and CCL2 (MCP-1) expression in mast cell-deficient mice indicates a collaborative relationship between mast cells and macrophages, which may contribute to restricting DENV infection at the skin inoculation site.
Mouse models for DENV disease are imperfect surrogates for human DENV disease and generally require higher titres of DENV inoculation than is the case for humans. 34 Previous studies showed that intradermal inoculation of a wide range of DENV doses (4 9 10 7 to 3 9 10 9 PFU/mouse) in mice caused different levels of haemorrhage and thrombocytopenia. 25 Using this model in our study (1 9 10 9 DENV PFU/mouse), we found that Kit W-sh/W-sh mice are more susceptible to intradermal DENV infection than WT mice, as indicated by increased NS3 staining at the skin inoculation site. Our results suggest a role for both mast cells and macrophages in modulating DENV infection in skin and accompanying pathological manifestations, including a more prolonged bleeding time and a higher level of F4/80-positive macrophage infiltration in Kit W-sh/W-sh mice. Our results reveal an intriguing dynamic between mast cells and skin macrophages. The basal levels of infiltrating macrophages and CCL2 (MCP-1) were higher in uninfected Kit W-sh/W-sh mice than in WT mice. DENV infection induced significantly increased CCL2 (MCP-1) The culture supernatants were assayed for the production of CCL2 (MCP-1) by ELISA. The averages of triplicate cultures AE SD are shown. *P < 0Á05; **P < 0Á01; ***P < 0Á001. get of DENV infection. 35 As we found that the basal numbers of infiltrating macrophages were higher in Kit W-sh/W-sh than in WT mice, it is likely that the greater availability of macrophages in mast cell-deficient mice accounts for the observed higher DENV infection in these mice. Interestingly, our results indicated an intrinsic (i.e. mast cell-independent) difference in macrophages from WT and Kit W-sh/W-sh mice. The ex vivo experimental results showed that peritoneal macrophages isolated from Kit W-sh/W-sh mice expressed more DENV NS4B antigen and secreted higher levels of CCL2 (MCP-1) after DENV infection compared with WT mice. The mechanism underlying the differential macrophage sensitivity to DENV remains unknown and is worthy of further investigation.
The role of mast cells in DENV infection is complex. Previous in vitro studies indicated that antibody-enhanced DENV infection of mast cells induces chemokines CCL3 (MIP-1a), CCL4 (MIP-1b) and CCL5 (RANTES) 13 as well as cytokines IL-6, IL-1b and TNF-a production.
14 Furthermore, the TNF-a produced from antibodyenhanced DENV infection of mast cells can trigger endothelial cell activation. 15 These results suggest that mast cells may play a pathogenic role in DENV infection. However, specific chemokines, such as CCL4 (MIP-1b), CCL5 (RANTES) and CXCL10 (IP-10) released from mast cells could also contribute to the recruitment of T cells and NK cells, both of which are important for suppressing viral infection. [16] [17] [18] Mast cells also contribute to immune surveillance, responding to DENV by activating host antiviral responses and releasing chemokines CX3CL1 (Fractalkine), CXCL12 (SDF-1) and CCL5 (RANTES) that recruit additional immune cells. 17, 18 Mast cells produce TNF-a, which activates endothelial cells 15 as well as chymase which can increase vascular permeability. 12 Coupled with the well-known chemokine responses of DENV-infected mast cells, these findings suggest that the response of mast cells to DENV can be both beneficial as well as detrimental. During DENV infection, mast cells can also trigger an antiviral response by releasing granules and by up-regulating intracellular antiviral molecules (e.g. RIG-I and MDA5). 16, 18, 19 The activated mast cells also produce chemokines, which recruit NK, NKT and T cells and then help to clear the virus. However, if local control mechanisms fail, the virus will enter the blood and be carried to other organs. The activated mast cells in these organs undergo degranulation to release proteases and inflammatory mediators. These mediators further increase the permeability of endothelial cells, leading to vascular leakage. However, the factors that determine whether the overall or net mast cell response is beneficial or harmful to the host are still unclear. 36 In our study, we found significant differences in several pathological features of DENV-infected mast cell-deficient Kit W-sh/W-sh mice compared with WT mice. Although previous studies showed that the numbers of immune cells such as macrophages, B cells, T cells, dendritic cells and NK cells are normal in Kit W-sh/W-sh mice, 24 the tissue distributions of these cells are less clear. We found that the basal levels of CCL2 (MCP-1) and local skin macrophages were higher in Kit W-sh/W-sh mice. CCL2 (MCP-1) is produced by many cell types, including macrophages, fibroblasts, epithelial cells and endothelial cells. 37 However, monocytes/macrophages are likely major sources of CCL2 (MCP-1). 38 Moreover, CCL2 (MCP-1) is also a potent chemotactic factor for monocytes/macrophages. 39 In patients with severe dengue, increased levels of CCL2 (MCP-1) have been observed. The CCL2 (MCP-1) levels were also associated with marked thrombocytopenia and hypotension. 30, 40 Our findings indicate that macrophages from DENV-infected Kit W-sh/W-sh mice were more infectable and produced more CCL2 (MCP-1) than those from WT mice. DENV-associated pathogenesis was also heightened in Kit W-sh/W-sh mice, as indicated by increased bleeding times.
In addition to increased levels of CCL2 (MCP-1), we also found that CCL5 (RANTES) and CXCL10 (IP-10) were higher in DENV-infected Kit W-sh/W-sh mice compared with WT mice (see Supplementary material, Figs S6-S8). These results were unexpected since mast cells infected with DENV in vitro produce increased levels of several chemokines including CCL5 (RANTES) and CXCL10 (IP-10) 13, 16 . The present in vivo study showing 
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